| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 08/01/2002 | US20020102722 Lac shuttle vectors |
| 08/01/2002 | US20020102702 Enzymatic polypeptide for use in the detergents |
| 08/01/2002 | US20020102698 Gene encoding alkaline liquefying alpha-amylase |
| 08/01/2002 | US20020102696 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide |
| 08/01/2002 | US20020102670 DNA coding for protein which confers on bacterium Escherichia coli resistance to L-homoserine, and method for producing L-amino acids |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102650 Generating preferential heterologous protein in culture; obtain cells, transform with expression vector containing heterologous protein, recover transformed cells, propagate, culture, express and recover heterologous proteins |
| 08/01/2002 | US20020102635 Methods for making and using a thermophilic enzyme as a beta-glycosidase |
| 08/01/2002 | US20020102618 Drosophila derived receptors of the steroid receptor superfamily |
| 08/01/2002 | US20020102327 Novel bread improving composition |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule |
| 08/01/2002 | US20020102254 For diagnostic and therapeutic uses in cancer |
| 08/01/2002 | CA2435910A1 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 07/31/2002 | EP1227154A2 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
| 07/31/2002 | EP1226264A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/31/2002 | EP1226236A1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1115841A4 Stable neural stem cell lines |
| 07/31/2002 | EP0944336B1 Cloudy fruit juices and methods for making same |
| 07/31/2002 | EP0760863B1 Method and means for the production of hyaluronic acid |
| 07/31/2002 | EP0744955B1 Cyclic heptapeptide anti-inflammatory agent |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | CN1361825A Novel antifungal agents and fungicides method for the production thereof and their use |
| 07/31/2002 | CN1361820A Method for stabilizing nitrilase activity and preserving microbial cells |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426211 Xylanase derived from a Bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
| 07/30/2002 | US6426204 Method for detecting candida infection |
| 07/30/2002 | CA2226293C Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/30/2002 | CA2148683C Potentiator of bacillus pesticidal activity |
| 07/30/2002 | CA2084673C 16 kda surface protein of p.falciparum |
| 07/30/2002 | CA2029201C Process for purifying b pertussis antigens |
| 07/25/2002 | WO2002057476A2 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 07/25/2002 | WO2002057475A1 Stereoselective preparation of 3-hydroxy-3-phenylpropionitrile |
| 07/25/2002 | WO2002057474A2 Processes for enhanced production of pantothenate |
| 07/25/2002 | WO2002057442A1 Gene disrupted yeast |
| 07/25/2002 | WO2002036756A3 Lactobacillus strain, and plasmid hosted by same |
| 07/25/2002 | US20020100074 Method for producing transformed plant having increased glutamic acid content |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099181 Anti-fibroblast growth factor-8 monoclonal antibody |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020098586 Method of and apparatus for cultivating a cell or tissue |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098562 Enzymatic polypeptide for use in the generation of 2-pyrone-4,6-dicarboxylic acid |
| 07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
| 07/25/2002 | US20020098557 Chemically reducing preferential compounds; obtain cmpounds, incubate with bacteria, recover reduced products |
| 07/25/2002 | US20020098556 Generating preferential compound in culture; obtain genetically engineered bacteria, culturing, recover preferential compound |
| 07/25/2002 | US20020098555 Microorganism; for use in the generation of arginine; for use in food processing; for use in activating liver health |
| 07/25/2002 | US20020098552 Method for producing xanthosine-5'-monophosphate by fermentation using mutant strains of Coryneform bacteria |
| 07/25/2002 | US20020098542 Novel forms of T cell costimulatory molecules and uses therefor |
| 07/25/2002 | US20020098470 Cryogenic stabilization of cells; obtain cells, inject with cryogenic agent, activate latent state, store cells |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
| 07/25/2002 | CA2434518A1 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 07/25/2002 | CA2434483A1 Processes for enhanced production of pantothenate |
| 07/25/2002 | CA2433650A1 Gene disrupted yeast |
| 07/24/2002 | EP1225230A1 Methods for producing L-amino acids |
| 07/24/2002 | EP1225227A1 Improved saccharification of cellulose by cloning and amplification of the beta-glucosidase gene of trichoderma reesei |
| 07/24/2002 | EP1225226A1 Peptides and nucleic acid sequences related to Epstein Barr Virus |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225219A1 Method for cloning and expression of BstYI restriction endonuclease and BstYI methylase in E. coli and purification of BstYI and M.BstYI enzymes |
| 07/24/2002 | EP1225184A1 Human antithrombin variants |
| 07/24/2002 | EP1224331A2 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays |
| 07/24/2002 | EP1224315A2 Microbiological methods for the production of aromatic aldehydes and/or carboxylic acids |
| 07/24/2002 | EP1224314A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 07/24/2002 | EP1224312A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 07/24/2002 | EP1224311A1 Recombinant, replication defective celo virus and celo virus dna |
| 07/24/2002 | EP1224306A1 Expression system for membrane proteins |
| 07/24/2002 | EP1224298A1 Fibrinolytically active polypeptide |
| 07/24/2002 | EP1224296A1 L-pantolactone-hydrolase and a method for producing d-pantolactone |
| 07/24/2002 | EP1224295A1 Method and compositions for improved polynucleotide synthesis |
| 07/24/2002 | EP1224294A2 Mutant luciferase |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1224279A2 Microbe, microbial exopolysaccharide, and uses thereof |
| 07/24/2002 | EP1224271A1 Expression of recombinant mature lysostaphin |
| 07/24/2002 | EP1224260A2 Methods for improving viral vector titers and reducing cell death in cell cultures |
| 07/24/2002 | EP1223970A1 Short segments of dap-kinase |
| 07/24/2002 | EP1082021B1 Process for the manufacture of probiotic cheese |
| 07/24/2002 | EP0938679B1 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 07/24/2002 | EP0837870B1 Synthetic modification to spinosyn compounds |
| 07/24/2002 | EP0793714B1 Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells |
| 07/24/2002 | EP0649465B1 Morphinone reductase for the preparation of hydromorphone and hydrocodone |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360677A Electrochemical method for enrichment of microorganism, biosensor for analyzing organic substance and BOD |
| 07/24/2002 | CN1360638A Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 07/24/2002 | CN1360636A Modified human granulocyte-colony stimulating factor and process for producing same |
| 07/24/2002 | CN1360630A Glucoamylase variant |
| 07/24/2002 | CN1360594A Attenuated microorganisms for treatment of infection |
| 07/24/2002 | CN1088102C Bleaching compositions comprising protease enzymes |
| 07/24/2002 | CN1087941C Compositions for prevention and treatment of viral-induced tumors |
| 07/23/2002 | US6423836 Production and use of human nm23 protein and antibodies therefor |
| 07/23/2002 | US6423828 Genetically engineered insecticidal endotoxins |
| 07/23/2002 | US6423524 Cellulase preparation comprising an endoglucanase enzyme |